为了获得访问"阿拉丁铁蛋"实时聊天框的流畅支持体验，建议您使用Chrome浏览器或选择360浏览器极速模式(如何切换极速模式?)，感谢您选择我们！
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| Ab096516-10μl |
10μl |
现货  |
| |
| Ab096516-50μl |
50μL |
现货 |
| |
| Ab096516-100μl |
100μL |
期货 |
| |
| Ab096516-1ml |
1ml |
期货 |
|
| 产品名称 | cIAP2 Mouse mAb |
|---|---|
| 别名 | 含杆状病毒IAP重复蛋白3(BIRC3)单克隆抗体 |
| 英文别名 | AIP 1 antibody | AIP1 antibody | API 2 antibody | API2 antibody | Apoptosis inhibitor 2 antibody | Baculoviral IAP repeat containing 3antibody | Baculoviral IAP repeat containing protein 3 antibody | Baculoviral IAP repeat-containing protein 3 antibody | |
| 规格或纯度 | ExactAb™, Validated, 1.0 mg/mL |
| 宿主种属 | Mouse |
| 特异性 | BIRC3 |
| 种属反应性 | Human,Monkey |
| 免疫原 | Purified recombinant human c-IAP2 protein fragments expressed in E.coli (AA 25-267). |
| 阳性对照 | WB: Ramos, MCF7 and HeLa cell lysates. |
| 偶联 | Unconjugated |
| 克隆类型 | Monoclonal |
|---|---|
| 克隆号 | 1F12-E5-G12 |
| Format | Whole IgG |
| 亚型 | Mouse IgG1 |
| 轻链亚型 | kappa |
| SDS-PAGE | 150 kDa |
| 纯化方法 | Protein G purified |
| 物理外观 | Liquid |
| 储存缓冲液 | 10mM PBS, 50% Glycerol, 0.5% BSA, 0.02% Sodium azide, pH 7.3 |
| 防腐剂 | 0.02% Sodium azide |
| 浓度 | 1.0 mg/mL |
| 储存温度 | -20°C储存,避免反复冻融 |
| 运输条件 | 超低温冰袋运输 |
| 稳定性与储存 | Store at 4°C short term (1-2 weeks). Store at -20°C long term (24 months). Upon delivery aliquot. Avoid freeze/thaw cycle. |
cIAP2 Mouse mAb (Ab096516) - Western Blot
All lanes: cIAP2 Mouse mAb (Ab096516) at 1/2000 dilution
Samples: Lysates at 20 µg per lane
Secondary: Goat Anti-Mouse IgG H&L (HRP) (Ab138044) at 1/20000 dilution
Predicted band size: 68 kDa
Observed band size: 76, 79 kDa
Exposure time: 50.9 s
| 应用名称 | 稀释比例 |
|---|---|
| WB | 1/500-1/2000 |
通过匹配包装上的批号来查找并下载产品的 COA，每批产品都进行了严格的验证，您可放心使用！
| 批号(Lot Number) | 证书类型 | 日期 | 货号 |
|---|---|---|---|
 ZJ24F0102427 |
分析证书 | 24-01-15 | Ab096516 |
| ZJ24F0102428 |
分析证书 | 24-01-15 | Ab096516 |
| 1. Gyrd-Hansen M, Meier P. (2010) IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer.. Nat Rev Cancer, 10 (8): (561-74). [PMID:20651737] [10.1021/op500134e] |
| 2. Cai Q, Sun H, Peng Y, Lu J, Nikolovska-Coleska Z, McEachern D, Liu L, Qiu S, Yang CY, Miller R et al.. (2011) A potent and orally active antagonist (SM-406/AT-406) of multiple inhibitor of apoptosis proteins (IAPs) in clinical development for cancer treatment.. J Med Chem, 54 (8): (2714-26). [PMID:21443232] [10.1021/op500134e] |
| 3. Flygare JA, Beresini M, Budha N, Chan H, Chan IT, Cheeti S, Cohen F, Deshayes K, Doerner K, Eckhardt SG et al.. (2012) Discovery of a potent small-molecule antagonist of inhibitor of apoptosis (IAP) proteins and clinical candidate for the treatment of cancer (GDC-0152).. J Med Chem, 55 (9): (4101-13). [PMID:22413863] [10.1021/op500134e] |
| 1. Gyrd-Hansen M, Meier P. (2010) IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer.. Nat Rev Cancer, 10 (8): (561-74). [PMID:20651737] [10.1021/op500134e] |
| 2. Cai Q, Sun H, Peng Y, Lu J, Nikolovska-Coleska Z, McEachern D, Liu L, Qiu S, Yang CY, Miller R et al.. (2011) A potent and orally active antagonist (SM-406/AT-406) of multiple inhibitor of apoptosis proteins (IAPs) in clinical development for cancer treatment.. J Med Chem, 54 (8): (2714-26). [PMID:21443232] [10.1021/op500134e] |
| 3. Flygare JA, Beresini M, Budha N, Chan H, Chan IT, Cheeti S, Cohen F, Deshayes K, Doerner K, Eckhardt SG et al.. (2012) Discovery of a potent small-molecule antagonist of inhibitor of apoptosis (IAP) proteins and clinical candidate for the treatment of cancer (GDC-0152).. J Med Chem, 55 (9): (4101-13). [PMID:22413863] [10.1021/op500134e] |
首页
400-620-6333
